Contrary results were first presented by Yin et al. [172], who reported a 1.5-fold elevation of clusterin in pooled CSF from three PD patients as compared to three healthy controls, determined using one-dimensional electrophoresis followed by liquid chromatography–tandem mass spectrometry (LC-MS/MS). The gene discussed is CLU; the disease is Parkinson disease.